Literature DB >> 28461567

Kinase Activities of RIPK1 and RIPK3 Can Direct IFN-β Synthesis Induced by Lipopolysaccharide.

Danish Saleh1,2, Malek Najjar3, Matija Zelic4, Saumil Shah5, Shoko Nogusa6, Apostolos Polykratis7,8,9, Michelle K Paczosa10, Peter J Gough11, John Bertin11, Michael Whalen12, Katherine A Fitzgerald13, Nikolai Slavov14, Manolis Pasparakis7,8,9, Siddharth Balachandran6, Michelle Kelliher4, Joan Mecsas15, Alexei Degterev16,2,3,5.   

Abstract

The innate immune response is a central element of the initial defense against bacterial and viral pathogens. Macrophages are key innate immune cells that upon encountering pathogen-associated molecular patterns respond by producing cytokines, including IFN-β. In this study, we identify a novel role for RIPK1 and RIPK3, a pair of homologous serine/threonine kinases previously implicated in the regulation of necroptosis and pathologic tissue injury, in directing IFN-β production in macrophages. Using genetic and pharmacologic tools, we show that catalytic activity of RIPK1 directs IFN-β synthesis induced by LPS in mice. Additionally, we report that RIPK1 kinase-dependent IFN-β production may be elicited in an analogous fashion using LPS in bone marrow-derived macrophages upon inhibition of caspases. Notably, this regulation requires kinase activities of both RIPK1 and RIPK3, but not the necroptosis effector protein, MLKL. Mechanistically, we provide evidence that necrosome-like RIPK1 and RIPK3 aggregates facilitate canonical TRIF-dependent IFN-β production downstream of the LPS receptor TLR4. Intriguingly, we also show that RIPK1 and RIPK3 kinase-dependent synthesis of IFN-β is markedly induced by avirulent strains of Gram-negative bacteria, Yersinia and Klebsiella, and less so by their wild-type counterparts. Overall, these observations identify unexpected roles for RIPK1 and RIPK3 kinases in the production of IFN-β during the host inflammatory responses to bacterial infection and suggest that the axis in which these kinases operate may represent a target for bacterial virulence factors.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28461567      PMCID: PMC5471631          DOI: 10.4049/jimmunol.1601717

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  79 in total

1.  RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein.

Authors:  Akhil Rajput; Andrew Kovalenko; Konstantin Bogdanov; Seung-Hoon Yang; Tae-Bong Kang; Jin-Chul Kim; Jianfang Du; David Wallach
Journal:  Immunity       Date:  2011-03-25       Impact factor: 31.745

2.  RIPK1- and RIPK3-induced cell death mode is determined by target availability.

Authors:  W D Cook; D M Moujalled; T J Ralph; P Lock; S N Young; J M Murphy; D L Vaux
Journal:  Cell Death Differ       Date:  2014-06-06       Impact factor: 15.828

3.  The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia.

Authors:  Gabriela Brumatti; Chunyan Ma; Najoua Lalaoui; Nhu-Y Nguyen; Mario Navarro; Maria C Tanzer; Jennifer Richmond; Margherita Ghisi; Jessica M Salmon; Natasha Silke; Giovanna Pomilio; Stefan P Glaser; Elisha de Valle; Raffi Gugasyan; Mark A Gurthridge; Stephen M Condon; Ricky W Johnstone; Richard Lock; Guy Salvesen; Andrew Wei; David L Vaux; Paul G Ekert; John Silke
Journal:  Sci Transl Med       Date:  2016-05-18       Impact factor: 17.956

4.  Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF.

Authors:  Jean-Stéphane Gatot; Romain Gioia; Tieu-Lan Chau; Félicia Patrascu; Michael Warnier; Pierre Close; Jean-Paul Chapelle; Eric Muraille; Keith Brown; Ulrich Siebenlist; Jacques Piette; Emmanuel Dejardin; Alain Chariot
Journal:  J Biol Chem       Date:  2007-09-06       Impact factor: 5.157

5.  TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta.

Authors:  Jonathan C Kagan; Tian Su; Tiffany Horng; Amy Chow; Shizuo Akira; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2008-02-24       Impact factor: 25.606

Review 6.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

7.  Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice.

Authors:  Scott B Berger; Viera Kasparcova; Sandy Hoffman; Barb Swift; Lauren Dare; Michelle Schaeffer; Carol Capriotti; Michael Cook; Joshua Finger; Angela Hughes-Earle; Philip A Harris; William J Kaiser; Edward S Mocarski; John Bertin; Peter J Gough
Journal:  J Immunol       Date:  2014-05-12       Impact factor: 5.422

8.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

9.  RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL.

Authors:  Kate E Lawlor; Nufail Khan; Alison Mildenhall; Motti Gerlic; Ben A Croker; Akshay A D'Cruz; Cathrine Hall; Sukhdeep Kaur Spall; Holly Anderton; Seth L Masters; Maryam Rashidi; Ian P Wicks; Warren S Alexander; Yasuhiro Mitsuuchi; Christopher A Benetatos; Stephen M Condon; W Wei-Lynn Wong; John Silke; David L Vaux; James E Vince
Journal:  Nat Commun       Date:  2015-02-18       Impact factor: 14.919

10.  Akt Regulates TNFα synthesis downstream of RIP1 kinase activation during necroptosis.

Authors:  Colleen R McNamara; Ruchita Ahuja; Awo D Osafo-Addo; Douglas Barrows; Arminja Kettenbach; Igor Skidan; Xin Teng; Gregory D Cuny; Scott Gerber; Alexei Degterev
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

View more
  18 in total

1.  Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity.

Authors:  Annelise G Snyder; Nicholas W Hubbard; Michelle N Messmer; Sigal B Kofman; Cassidy E Hagan; Susana L Orozco; Kristy Chiang; Brian P Daniels; David Baker; Andrew Oberst
Journal:  Sci Immunol       Date:  2019-06-21

2.  NLRP3 Inflammasome Is Involved in Q-VD-OPH Induced Necroptosis Following Cerebral Ischemia-Reperfusion Injury.

Authors:  Xue Teng; Weiwei Chen; Zhihan Liu; Tao Feng; Hui Li; Sheng Ding; Yonggang Chen; Ying Zhang; Xianping Tang; Deqin Geng
Journal:  Neurochem Res       Date:  2018-05-25       Impact factor: 3.996

3.  PELI1 functions as a dual modulator of necroptosis and apoptosis by regulating ubiquitination of RIPK1 and mRNA levels of c-FLIP.

Authors:  Huibing Wang; Huyan Meng; Xingyan Li; Kezhou Zhu; Kangyun Dong; Adnan K Mookhtiar; Huiting Wei; Ying Li; Shao-Cong Sun; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-23       Impact factor: 11.205

4.  Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis.

Authors:  Adrian Schreiber; Anthony Rousselle; Jan Ulrich Becker; Anne von Mässenhausen; Andreas Linkermann; Ralph Kettritz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-24       Impact factor: 11.205

Review 5.  Multitasking Kinase RIPK1 Regulates Cell Death and Inflammation.

Authors:  Kim Newton
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-03-02       Impact factor: 10.005

6.  Immunoprecipitation Strategies to Isolate RIPK1/RIPK3 Complexes in Mouse Macrophages.

Authors:  Ioannis Siokas; Dingqiang Zhang; Alexander Poltorak; Hayley Muendlein; Alexei Degterev
Journal:  Curr Protoc       Date:  2021-06

7.  Swine Influenza Virus Induces RIPK1/DRP1-Mediated Interleukin-1 Beta Production.

Authors:  Hong-Su Park; Guanqun Liu; Qiang Liu; Yan Zhou
Journal:  Viruses       Date:  2018-08-09       Impact factor: 5.048

Review 8.  RIPK protein kinase family: Atypical lives of typical kinases.

Authors:  Gregory D Cuny; Alexei Degterev
Journal:  Semin Cell Dev Biol       Date:  2020-07-27       Impact factor: 7.727

9.  Is Receptor-Interacting Protein Kinase 3 a Viable Therapeutic Target for Mycobacterium tuberculosis Infection?

Authors:  Michael D Stutz; Samar Ojaimi; Gregor Ebert; Marc Pellegrini
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561

10.  c-Jun N-terminal kinases differentially regulate TNF- and TLRs-mediated necroptosis through their kinase-dependent and -independent activities.

Authors:  Mengtao Cao; Fei Chen; Ni Xie; Meng-Yao Cao; Pengfei Chen; Qi Lou; Yanli Zhao; Chen He; Shuyuan Zhang; Xinyang Song; Yu Sun; Weimin Zhu; Lisha Mou; Shaodong Luan; Hanchao Gao
Journal:  Cell Death Dis       Date:  2018-11-15       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.